Cleared Traditional

K233498 - Stryker Orthopaedics Hip Systems Labeli...

K233498 is the FDA 510(k) clearance for Stryker Orthopaedics Hip Systems Labeli... by Howmedica Osteonics Corp., Dba Stryker Orthopaedics. It is a Class 2 Orthopedic device (product code LPH) cleared through the Traditional 510(k) pathway after a 51-day FDA review.

K233498 · Howmedica Osteonics Corp., Dba Stryker Orthopaedics · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2023
Decision
51d
Days
Class 2
Risk

K233498 is an FDA 510(k) clearance for the Stryker Orthopaedics Hip Systems Labeling Update. Classified as Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented (product code LPH), Class II - Special Controls.

Submitted by Howmedica Osteonics Corp., Dba Stryker Orthopaedics (Mahwah, US). The FDA issued a Cleared decision on December 21, 2023 after a review of 51 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3358 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Howmedica Osteonics Corp., Dba Stryker Orthopaedics devices

Submission Details

510(k) Number K233498 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 31, 2023
Decision Date December 21, 2023
Days to Decision 51 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
71d faster than avg
Panel avg: 122d · This submission: 51d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3358
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented

All 428
Devices cleared under the same product code (LPH) and FDA review panel - the closest regulatory comparables to K233498.
OR3O Dual Mobility System
K242375 · Smith & Nephew, Inc. · Oct 2024
Ethylene Oxide Sterilization Supplier Change for MPO Hips
K240046 · Microport Orthopedics · Apr 2024
EMPHASYS™ Dual Mobility System
K231522 · Depuy Ireland UC · Feb 2024
OR3O Dual Mobility Liners
K232667 · Smith & Nephew, Inc. · Oct 2023
Mpact Extension
K230011 · Medacta International S.A. · Sep 2023
DePuy 3D Additive TriFlange Acetabular Cup and DePuy TriFlange II Acetabular Cup System
K232556 · Depuy Ireland UC · Sep 2023